International Clinical Expansion for Examen Lab Limited
Advanced Sperm DNA Testing for fertility clinics ready to look beyond standard semen analysis
Examen Global Supports IVF clinics, fertility hospitals, urologists, embryologists, and reproductive medicine leaders with advanced sperm DNA Fragmentation Testing powered by SpermComet® Technology.
Helping clinical terms indentify hidden male factor insights that count, motility, and morphology assessment may not fully reveal.
The diagnostic gap
The male fertility diagnostic gap clinics can no longer ignore.
Standard semen analysis remains useful for assessing count, motility, morphology, and baseline parameters. However, clinics regularly encounter patients with apparently acceptable semen parameters who still face unexplained infertility, recurrent pregnancy loss, poor embryo development, or repeated ART failure.
Advanced Sperm DNA Testing can help clinicians ask better questions, strengthen counselling, and make more informed decisions within a complete male fertility pathway.
Traditional semen analysis
Count
Motility
Morphology
Volume
Baseline parameters
Advanced Sperm DNA Testing
Single strand DNA damage
Double strand DNA damage
Incidence of DNA damage
Deeper male factor insight
Clinical decision support
Paradigm shift
From legacy semen analysis to modern DNA level male fertility insight.
The fertility field has advanced in stimulation protocols, embryology, cryopreservation, and laboratory quality. EXAMEN Global helps clinics modernise the male factor pathway by adding deeper DNA level insight that complements existing assessment.
Past
Count, motility, morphology
Useful baseline information, but limited DNA level visibility.
Present
Sperm DNA Fragmentation Testing
Deeper insight into sperm DNA integrity where clinically appropriate.
Future
Integrated male fertility diagnostics
A stronger, evidence based pathway for clinics and patients.
Science and evidence
Evidence based Sperm DNA Testing backed by Examen research.
Examen’s scientific foundation is built around SpermComet® technology and published research into sperm DNA damage, including single strand and double strand fragmentation. Clinicians are encouraged to review Examen’s evidence base directly.
DNA level insight
Supports deeper assessment beyond count, motility, and morphology.
Responsible interpretation
Designed to complement clinical judgement, not replace it.
Clinician led pathway
Testing decisions should be made by appropriately qualified professionals.
Clinic value
Why leading fertility clinics should consider Examen.
Deeper male factor insight
Advanced Sperm DNA Testing can help identify hidden sperm DNA damage that may not be visible through standard semen analysis alone.
Stronger clinical conversations
Supports more informed counselling around unexplained infertility, recurrent loss, previous ART failure, lifestyle factors, and urology referral.
Clinic differentiation
Clinics may consider Sperm DNA Testing in selected cases under appropriate clinical guidance and in line with local professional standards.
Commercially practical
Creates a premium diagnostic pathway that can support clinical quality, patient trust, and service differentiation.
International logistics support
Supports practical onboarding models for the UAE, MEA, India, GCC, UK, and other international markets.
No major capital investment
Clinics can access specialist Belfast based testing through structured logistics pathways rather than building complex onsite capability.
Commercial value
Premium testing. Practical economics. Stronger patient pathways.
For clinics, the value of advanced Sperm DNA Testing is not only the test fee. It is the ability to strengthen the male fertility pathway, improve patient counselling, support more targeted decision making, and create a differentiated clinical service.
Indicative regional test pricing
AED 3,250 to AED 4,500
Subject to clinic model, region, logistics, volume, and local regulation.
Clinical pathway
Where Sperm DNA Testing may fit within the fertility pathway.
Clinics may consider Sperm DNA Testing in selected cases under appropriate clinical guidance and in line with local professional standards.
Unexplained infertility
Recurrent pregnancy loss
Previous IVF or ICSI failure
Poor embryo development
Male factor infertility
Older paternal age
Varicocele assessment pathway
Lifestyle or oxidative stress risk factors
Before repeat ART cycles where clinically appropriate
After urology or andrology review where indicated
ABout Examen
Specialist male fertility diagnostics from Belfast, United Kingdom.
Examen Lab Limited is a Belfast based specialist laboratory focused on advanced male fertility diagnostics. Through SpermComet® technology and a strong research heritage, Examen supports clinicians seeking deeper insight into sperm DNA damage and its potential relevance within the fertility pathway.
Meet your onboarding lead
Dr. Deepak Songra BDS
Dr. Deepak Songra BDS is Global Development Manager for Examen Lab Limited across MEA, UAE, India, and international markets. With more than 30 years of clinical healthcare experience, he works with IVF clinics, fertility hospitals, urologists, embryologists, laboratory groups, and healthcare partners to support the international integration of advanced Sperm DNA Testing.
Clinical positioning
Commercial viability
Logistics and sample movement
Patient pathway integration
Regional partnership opportunities
ROI modelling
Mission
To help fertility clinics worldwide access advanced Sperm DNA Testing that supports deeper male fertility insight, stronger clinical decision making, and more complete patient counselling.
Vision
To make DNA level male fertility assessment a recognised and accessible part of modern reproductive medicine pathways across international markets.
Values
Scientific integrity, clinical responsibility, evidence based communication, patient centred care, commercial transparency, international partnership, and regulatory compliance.
Professional guide
The Clinic Leader’s Guide to Integrating Advanced Sperm DNA Testing into the Male Fertility Pathway.
A practical guide for IVF clinics, fertility hospitals, urologists, and reproductive medicine teams considering Sperm DNA Fragmentation Testing as part of a more complete male fertility assessment pathway.
Responsible communication
Built for responsible medical communication.
This website is intended for healthcare professionals, clinic leaders, and institutional partners. It does not provide patient specific medical advice. All testing decisions must be made by appropriately qualified clinicians.
DDA aligned design
WCAG 2.2 AA oriented accessibility
Clinician led interpretation
Regional regulatory review required
Clear medical disclaimers
Evidence based copy controls
FAQ
Questions clinic leaders often ask
It is a laboratory assessment designed to provide insight into sperm DNA damage, complementing standard semen analysis where clinically appropriate.
Semen analysis measures baseline parameters such as count, motility, and morphology. Sperm DNA Testing looks deeper at DNA integrity, which may be relevant in selected clinical pathways.
No. It is designed to complement, not replace, semen analysis, clinical assessment, urology input, embryology review, or clinician judgement.
Clinics may consider testing in selected cases including unexplained infertility, recurrent pregnancy loss, previous ART failure, poor embryo development, or male factor assessment.
Testing is performed through Examen’s specialist Belfast based laboratory pathway.
Yes, subject to local regulatory, logistics, consent, and specimen transport requirements being reviewed and approved.
Not necessarily. EXAMEN Global is designed around practical hub and dry shipper models that can avoid the need for complex onsite specialist testing infrastructure.
Use the booking form below or contact Dr. Deepak Songra directly by email, WhatsApp, or telephone.
Book A Briefing
Coordinate your Clinical Integration Briefing with Dr. Deepak Songra BDS.
Select an optimal slot for a 30 minute clinical, commercial, and logistics review.
Current operational window
08:00 AM to 18:00 PM UK GMT. Available 7 days a week.
Dubai, UAE: GMT plus 4 hours.
Mumbai and Delhi: GMT plus 4.5 hours.
Request a clinic ROI Simulator
